1) Marugame T, Kamo K, The Japan Cancer Surveillance Research Group:Cancer incidence and incidence rates in Japan in 2000:estimates based on data from 11 population-based cancer registries. Japanese Journal of Clinical Oncology 36:668-675, 2006
2) Whitney CW, Sause W, Bundy BN, et al:A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes:A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 17:1339-1348, 1999
3) Morris M, Eifel PJ, Lu J, et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143, 1999
4) Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al:Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606-1613, 2000
5) Rose PG, Bundy BN, Watkins EB, et al:Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153, 1999
6) Keys HM, Bundy BN, Stehman FB, et al:Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161, 1999
7) Rose PG, Bundy BN:Chemoradiation for locally advanced cervical cancer:Does it help? JClin Oncol 20:891-893, 2002
8) Green JA, Kirwan JM, Tierney JF, et al:Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis. Lancet 358:781-786, 2001
9) Green J, Kirwan J, Tierney J, et al:Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3:CD002225, 2005
10) Kirwan JM, Symonds P, Green JA, et al:A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68:217-226, 2003
11) Tseng CJ, Chang CT, Lai CH, et al:A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66:52-58, 1997
12) Rose PG, Lappas PT:Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer:Implications from five randomized trials. Gynecol Oncol 78:3-6, 2000
13) Manusirivithaya S, Sripramote M, Tangjitgamol S, et al:Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer. J Med Assoc Thai 88:1035-1044, 2005
14) Rocconi RP, Estes JM, Leath CA 3rd, et al:Management strategies for stage IB2 cervical cancer:a cost-effectiveness analysis. Gynecol Oncol 97:387-394, 2005
15) 日本産科婦人科学会,日本病理学会,日本医学放射線学会(編):子宮頸癌取扱い規約(改訂第2版).金原出版,東京,1997
16) Patrick T, Susan GA, Elizabeth AE, et al:New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216, 2000
17) Muennig P, Khan K:Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care. pp242-243, Jossey-Bass, 2002
18) Okubo I, Kondo M, Toi M, et al:Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. Jpn J Cancer Chemother 32:351-363, 2005
19) 医学通信社(編):DPC点数早見表:診断群分類樹形図と包括点数・対象疾患一覧.医学通信社,東京,2006